These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16753007)

  • 1. High-throughput mutational analysis of the human cancer genome.
    Ma PC; Zhang X; Wang ZJ
    Pharmacogenomics; 2006 Jun; 7(4):597-612. PubMed ID: 16753007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic mutations of ERBB2 kinase domain in gastric, colorectal, and breast carcinomas.
    Lee JW; Soung YH; Seo SH; Kim SY; Park CH; Wang YP; Park K; Nam SW; Park WS; Kim SH; Lee JY; Yoo NJ; Lee SH
    Clin Cancer Res; 2006 Jan; 12(1):57-61. PubMed ID: 16397024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic analyses of the cancer genome: lessons learned from sequencing most of the annotated human protein-coding genes.
    Sjöblom T
    Curr Opin Oncol; 2008 Jan; 20(1):66-71. PubMed ID: 18043258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide mutational analyses of breast and colorectal cancers.
    Lin J; Sjöblom T
    Discov Med; 2007 Feb; 7(37):13-9. PubMed ID: 17343800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High frequency of mutations of the PIK3CA gene in human cancers.
    Samuels Y; Wang Z; Bardelli A; Silliman N; Ptak J; Szabo S; Yan H; Gazdar A; Powell SM; Riggins GJ; Willson JK; Markowitz S; Kinzler KW; Vogelstein B; Velculescu VE
    Science; 2004 Apr; 304(5670):554. PubMed ID: 15016963
    [No Abstract]   [Full Text] [Related]  

  • 6. Somatic mutations in human cancer: insights from resequencing the protein kinase gene family.
    Futreal PA; Wooster R; Stratton MR
    Cold Spring Harb Symp Quant Biol; 2005; 70():43-9. PubMed ID: 16869737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosine phosphatases as a superfamily of tumor suppressors in colorectal cancer.
    Laczmanska I; Sasiadek MM
    Acta Biochim Pol; 2011; 58(4):467-70. PubMed ID: 22146137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis of gene families in human cancer.
    Bardelli A; Velculescu VE
    Curr Opin Genet Dev; 2005 Feb; 15(1):5-12. PubMed ID: 15661527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine kinase activating mutations in human malignancies: implications for diagnostic pathology.
    Holden JA; Willmore-Payne C; Layfield LJ
    Exp Mol Pathol; 2008 Aug; 85(1):68-75. PubMed ID: 18486128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor mutations in small cell lung cancer.
    Tatematsu A; Shimizu J; Murakami Y; Horio Y; Nakamura S; Hida T; Mitsudomi T; Yatabe Y
    Clin Cancer Res; 2008 Oct; 14(19):6092-6. PubMed ID: 18829487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiling the cancer genome.
    Cowin PA; Anglesio M; Etemadmoghadam D; Bowtell DD
    Annu Rev Genomics Hum Genet; 2010; 11():133-59. PubMed ID: 20590430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I study of neratinib in combination with temsirolimus in patients with human epidermal growth factor receptor 2-dependent and other solid tumors.
    Gandhi L; Bahleda R; Tolaney SM; Kwak EL; Cleary JM; Pandya SS; Hollebecque A; Abbas R; Ananthakrishnan R; Berkenblit A; Krygowski M; Liang Y; Turnbull KW; Shapiro GI; Soria JC
    J Clin Oncol; 2014 Jan; 32(2):68-75. PubMed ID: 24323026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung cancer: intragenic ERBB2 kinase mutations in tumours.
    Stephens P; Hunter C; Bignell G; Edkins S; Davies H; Teague J; Stevens C; O'Meara S; Smith R; Parker A; Barthorpe A; Blow M; Brackenbury L; Butler A; Clarke O; Cole J; Dicks E; Dike A; Drozd A; Edwards K; Forbes S; Foster R; Gray K; Greenman C; Halliday K; Hills K; Kosmidou V; Lugg R; Menzies A; Perry J; Petty R; Raine K; Ratford L; Shepherd R; Small A; Stephens Y; Tofts C; Varian J; West S; Widaa S; Yates A; Brasseur F; Cooper CS; Flanagan AM; Knowles M; Leung SY; Louis DN; Looijenga LH; Malkowicz B; Pierotti MA; Teh B; Chenevix-Trench G; Weber BL; Yuen ST; Harris G; Goldstraw P; Nicholson AG; Futreal PA; Wooster R; Stratton MR
    Nature; 2004 Sep; 431(7008):525-6. PubMed ID: 15457249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Developments in cancer management by innovative genomics. 2006 report of the National Cancer Consortium].
    Tímár J; Kásler M; Kátai J; Soós M; Mathiasz D; Romány A; Patthy L; Kovács G; Józsa A; Szilák L; Forrai T
    Magy Onkol; 2006; 50(4):349-59. PubMed ID: 17216011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of colorectal cancer with double-activating epidermal growth factor receptor mutations.
    Rai K; Fujiwara K; Tsushima M; Kudo K; Mizuta M; Matsuo K; Yonei T; Yamadori I; Kiura K; Sato T
    Jpn J Clin Oncol; 2011 Sep; 41(9):1138-41. PubMed ID: 21835826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational profiling of cancer candidate genes in glioblastoma, melanoma and pancreatic carcinoma reveals a snapshot of their genomic landscapes.
    Bleeker FE; Lamba S; Rodolfo M; Scarpa A; Leenstra S; Vandertop WP; Bardelli A
    Hum Mutat; 2009 Feb; 30(2):E451-9. PubMed ID: 19058223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancers.
    Wood LD; Calhoun ES; Silliman N; Ptak J; Szabo S; Powell SM; Riggins GJ; Wang TL; Yan H; Gazdar A; Kern SE; Pennacchio L; Kinzler KW; Vogelstein B; Velculescu VE
    Hum Mutat; 2006 Oct; 27(10):1060-1. PubMed ID: 16941478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics and pharmacogenomics: role of mutational analysis in anti-cancer targeted therapy.
    Savonarola A; Palmirotta R; Guadagni F; Silvestris F
    Pharmacogenomics J; 2012 Aug; 12(4):277-86. PubMed ID: 22760589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation in the tyrosine kinase domain of epidermal growth factor receptor is a predictive and prognostic factor for gefitinib treatment in patients with non-small cell lung cancer.
    Chou TY; Chiu CH; Li LH; Hsiao CY; Tzen CY; Chang KT; Chen YM; Perng RP; Tsai SF; Tsai CM
    Clin Cancer Res; 2005 May; 11(10):3750-7. PubMed ID: 15897572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel somatic and germline mutations in cancer candidate genes in glioblastoma, melanoma, and pancreatic carcinoma.
    Balakrishnan A; Bleeker FE; Lamba S; Rodolfo M; Daniotti M; Scarpa A; van Tilborg AA; Leenstra S; Zanon C; Bardelli A
    Cancer Res; 2007 Apr; 67(8):3545-50. PubMed ID: 17440062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.